P
Pharming Group N.V. (PHAR)
NGM – Real Time Price. Currency in USD
16.31
+0.18 (1.12%)
At close: Mar 27, 2026, 4:00 PM EDT
16.31
+0.01 (0.06%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
16.31
+0.18 (1.12%)
At close: Mar 27, 2026, 4:00 PM EDT
16.31
+0.01 (0.06%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.59 | 6.05 | 10 | |
| Quick ratio | 2.03 | 5.63 | 10 | |
| Debt to Equity | 0.42 | 0.30 | 7.0 | |
| Debt to Assets | 0.23 | 1.04 | 7.0 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 8.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 206M | 246M | 297M | 377M | 377M |
| Gross Profit | 184M | 209M | 250M | 332M | 331M |
| Operating Income | 4M | -22M | -4M | 19M | 29M |
| Net Income | 14M | -11M | -12M | 3M | 3M |
| EBITDA | 13M | -11M | 7M | 31M | 41M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 18.53 | 102.95 | 9.5 |
| Next quarter | 10.41 | -83.33 | 4.0 |
| Current year | 7.72 | 321.25 | 8.0 |
| Next year | 2.17 | 20.92 | 6.5 |
| Weighted average score | 7.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 9.87 | -29.06 | -29.99 | -76.2 | 2.3 |
| Y/Y | 15.62 | 44.16 | 40 | 4.74 | 8.3 |
| 3y average | 22.45 | -21.62 | -20.19 | 212.8 | 5.5 |
| 5y average | 12.95 | -27.35 | -27.63 | 108.72 | 5.0 |
| Weighted average score | 5.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $146.1M significantly exceed its total debt $115.8M, ensuring strong financial flexibility
Total current assets $299.5M exceed Total current liabilities $115.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $7.1M, supporting its financial health